دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Impact of Complete Revascularization in the ISCHEMIA Trial
Gregg W. Stone, MD, a Ziad A. Ali, MD, DP HIL, b,c Sean M. O’Brien, P HD, d Grace Rhodes, MS,d Philippe Genereux, MD,e Sripal Bangalore, MD, MHA, f Kreton Mavromatis, MD, g Jennifer Horst, MS, c Ovidiu Dressler, MD, c Kian Keong Poh, MD,h Ranjit K. Nath, MD,i Nagaraja Moorthy, MD,j Adam Witkowski, MD, k Sudhanshu K. Dwivedi, MD,l Olga Bockeria, MD, m Jiyan Chen, MD, n Paola E.P. Smanio, MD, o Michael H. Picard, MD, p Bernard R. Chaitman, MD,q Daniel S. Berman, MD, r Leslee J. Shaw, P HD, a William E. Boden, MD,s Harvey D. White, MB, C HB, t Stephen E. Fremes, MD, u Yves Rosenberg, MD, MPH,v Harmony R. Reynolds, MD, f John A. Spertus, MD, MPH,w Judith S. Hochman, MD,f David J. Maron, MD,x on behalf of the ISCHEMIA Research Group
doi : 10.1016/j.jacc.2023.06.015
Volume 82, Issue 12, 19 September 2023, Pages 1175-1188
Complete Coronary Revascularization∗: A New Strategy to Improve Clinical Outcomes for Stable Coronary Artery Disease?
Jane A. Leopold, MD
doi : 10.1016/j.jacc.2023.07.008
Volume 82, Issue 12, 19 September 2023, Pages 1189-1191
Association of Coronary Artery Calcium Detected by Routine Ungated CT Imaging With Cardiovascular Outcomes
Allison W. Peng, MD,a,b Ramzi Dudum, MD, MPH, b,c Sneha S. Jain, MD, MBA, b,c David J. Maron, MD,b,c,d Bhavik N. Patel, MD, MBA, e Nishith Khandwala, MS, f David Eng, MS, f Akshay S. Chaudhari, PHD, b,g,h Alexander T. Sandhu, MD, MS, b,c,i, * Fatima Rodriguez, MD, MPH
doi : 10.1016/j.jacc.2023.06.040
Volume 82, Issue 12, 19 September 2023, Pages 1192-1202
Incidental Coronary Artery Calcium: Nothing Is More Expensive Than a Missed Opportunity∗
Roger S. Blumenthal, MD, Jelani Grant, MD, Seamus P. Whelton, MD, MPH
doi : 10.1016/j.jacc.2023.06.039
Volume 82, Issue 12, 19 September 2023, Pages 1203-1205
20-Year Experience With Repair of Pulmonary Atresia or Stenosis and Major Aortopulmonary Collateral Arteries
Doff B. McElhinney, MD,a,b Ritu Asija, MD,b Yulin Zhang, P HD, a Ayush Jaggi, MPH, a Jennifer Shek, NP, b Lynn F. Peng, MD,b M. Gail Boltz, MD, c Michael Ma, MD, a Elisabeth Martin, MD, MPH, a Frank L. Hanley, MD
doi : 10.1016/j.jacc.2023.06.041
Volume 82, Issue 12, 19 September 2023, Pages 1206-1222
Generating High-Quality Outcomes in Children With MAPCAs∗
Bryan H. Goldstein, MD
doi : 10.1016/j.jacc.2023.08.003
Volume 82, Issue 12, 19 September 2023, Pages 1223-1225
Survival After Cardiac Transplantation in Adults With Single-Ventricle Congenital Heart Disease
Syed Shahyan Bakhtiyar, MD, a,b Sara Sakowitz, MPH, a Konmal Ali, a Nikhil L. Chervu, MD, a Arjun Verma, a Ming-Sing Si, MD, c David D’Alessandro, MD, d Peyman Benharash, MD
doi : 10.1016/j.jacc.2023.06.037
Volume 82, Issue 12, 19 September 2023, Pages 1226-1241
Transplant in Single Ventricle Physiology: The Fourth Stage?∗
Daphne T. Hsu, MD, a George K. Lui, MD
doi : 10.1016/j.jacc.2023.06.038
Volume 82, Issue 12, 19 September 2023, Pages 1242-1244
Comprehensive Management of ANOCA, Part 1—Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review
Bruce A. Samuels, MD,a, * Samit M. Shah, MD, PH D, b,c, * R. Jay Widmer, MD, PH D, d Yuhei Kobayashi, MD, e Steven E.S. Miner, MDCM, f,g,h Viviany R. Taqueti, MD, MPH,i Allen Jeremias, MD, MS,j Ahmed Albadri, MD,a John A. Blair, MD, k Kathleen E. Kearney, MD,l Janet Wei, MD, a Ki Park, MD, m Ailin Barseghian El-Farra, MD,n Noa Holoshitz, MD, o Katherine B. Janaszek, MSN, NP-BC, p Manoj Kesarwani, MD,q Amir Lerman, MD,r Megha Prasad, MD, MS,s Odayme Quesada, MD,t,u Harmony R. Reynolds, MD, v Michael P. Savage, MD,w Nathaniel R. Smilowitz, MD, MS, x,y Nadia R. Sutton, MD, MPH,z,aa Joseph M. Sweeny, MD, bb Olga Toleva, MD, MPH,cc Timothy D. Henry, MD, u Jeffery W. Moses, MD,j,s William F. Fearon, MD, dd,ee,ff Jennifer A. Tremmel, MD, MS, dd on behalf of the Microvascular Network (MVN)
doi : 10.1016/j.jacc.2023.06.043
Volume 82, Issue 12, 19 September 2023, Pages 1245-1263
Comprehensive Management of ANOCA, Part 2—Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review
Nathaniel R. Smilowitz, MD, MS, a,b, * Megha Prasad, MD, MS, c, * R. Jay Widmer, MD, PHD, d Olga Toleva, MD, MPH,e Odayme Quesada, MD,f,g Nadia R. Sutton, MD, MPH,h,i Amir Lerman, MD,j Harmony R. Reynolds, MD, k Manoj Kesarwani, MD,l Michael P. Savage, MD, m Joseph M. Sweeny, MD,n Katherine B. Janaszek, MSN, NP-BC, o Ailin Barseghian El-Farra, MD,p Noa Holoshitz, MD, q Ki Park, MD,r Ahmed Albadri, MD, s John A. Blair, MD, t Allen Jeremias, MD, MSC ,u Kathleen E. Kearney, MD, v Yuhei Kobayashi, MD,w Steven E.S. Miner, MDCM, x,y Bruce A. Samuels, MD, s Samit M. Shah, MD, PH D, z,aa Viviany R. Taqueti, MD, MPH, bb Janet Wei, MD,s William F. Fearon, MD,cc,dd Jeffery W. Moses, MD, ee,ff Timothy D. Henry, MD,gg Jennifer A. Tremmel, MD, MS,hh on behalf of the Microvascular Network (MVN)
doi : 10.1016/j.jacc.2023.06.044
Volume 82, Issue 12, 19 September 2023, Pages 1264-1279
Concerns Regarding the Report of 3-Year Outcomes of the Evolut Low Risk Trial
Fabio Barili, MD, PhD, MStat Amedeo Anselmi, MD, PhD William E. Boden, MD Miguel Sousa Uva, MD Alessandro Parolari, MD, PhD
doi : 10.1016/j.jacc.2023.05.071
Volume 82, Issue 12, 19 September 2023, Page e101
Reply: Concerns Regarding the Report of 3-Year Outcomes of the Evolut Low Risk Trial
John K. Forrest, MD Michael J. Reardon, MD
doi : 10.1016/j.jacc.2023.06.042
Volume 82, Issue 12, 19 September 2023, Page e103
